Saint Louis University Center for Vaccine Development

St Louis, Missouri 63104-1015

1 studies enrolling now · 51 studies all time

What they study most

Avian Influenza, COVID-19, Dengue, Influenza, Influenza Immunisation, Influenza, Human, Monkeypox, Plague, Pneumococcal Infection, Pneumonia, Pulmonary TB, Renal Impairment

Studies at this site

• A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults — Recruiting now
• Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults — Running, not enrolling
• Single-Dose Study to Evaluate the PKs of Pretomanid in Participants With Renal Impairment Compared to Participants With Normal Renal Function — Completed
• A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes — Running, not enrolling
• Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine — Completed
• A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox — Completed
• A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers — Completed
• A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza. — Completed
• COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial) — Completed
• Flublok or Fluzone With Advax-CpG55.2 or AF03 — Completed
• MVA Post-Event: Administration Timing and Boost Study — Completed
• ZIKA Vaccine in Naive Subjects — Completed
• Pilot Influenza Challenge Study — Running, not enrolling
• High Dose IMVAMUNE® in Vaccinia-Naive Individuals — Completed
• Pretomanid in Adults With Hepatic Impairment — Stopped early
• Chimpanzee Adenovirus and Self-Amplifying mRNA Prime-Boost Prophylactic Vaccines Against SARS-CoV-2 in Healthy Adults — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology — Completed
• Phase 1 Clinical Trial of Single-Vial ID93 + GLA-SE in Healthy Adults — Completed
• Adaptive COVID-19 Treatment Trial 4 (ACTT-4) — Completed
• Adaptive COVID-19 Treatment Trial 3 (ACTT-3) — Completed
• Adaptive COVID-19 Treatment Trial (ACTT) — Completed
• Adaptive COVID-19 Treatment Trial 2 (ACTT-2) — Completed
• H3N2 M2SR in Pediatric Population — Completed
• 2013/2017 H7N9 Prime-Boost Interval — Completed
• 2017 A/H7N9 IIV Revaccination — Completed
• Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza — Completed
• H1N1v Virus Challenge Study in Healthy Subjects — Completed
• Lyophilized IMVAMUNE® (1x10^8 TCID50) Versus Liquid IMVAMUNE® (1x10^8 TCID50) Administered Subcutaneously and a Lower Dose Liquid IMVAMUNE® (2x10^7 TCID50) Administered Intradermally — Completed
• Challenge Model for Assessment of Human TB Immunity — Completed
• BCG Vaccination Delivered Intradermally, Orally and by Combined Routes — Completed
• H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults — Completed
• Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Pediatric Populations — Completed
• H7N9 Mix and Match With AS03 and MF59 in Healthy Adults — Completed
• H7N9 Mix and Match With MF59 in Healthy Elderly Persons — Completed
• A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine — Completed
• H5N1 (Clade 2) Vaccination of Adults and Elderly — Completed
• Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE® — Completed
• Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers — Completed
• Phase II Tularemia Vaccine Comparison — Completed
• Peds Sanofi H1N1 Influenza Vaccine Administered at Two Dose Levels — Completed
• Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women — Completed
• 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women — Completed
• Novartis H1N1 Vaccine in Pregnant Women — Completed
• Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 — Completed
• Comparison of Flu Vaccine Doses in Children — Completed
• Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study — Withdrawn before enrolling
• Tetravalent Chimeric Dengue Vaccine Trial — Completed
• H5N1 Mix and Match With MF59 — Completed
• H1N1 Vaccine in Pregnant Women — Completed